InsiderClue
Stocks · Health care · Biological Products, (No Diagnostic Substances)

VivoSim Labs, INC.

VIVS Clue Score21
United States Fiscal year ends March CIK 0001497253
$0.18 +1.64% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.18 −97.22% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 12 Oct 2016. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueOperating incomeNet income
Fiscal year 2017Revenue4.2Operating income−38.6Net income−38.4Fiscal year 2018Revenue4.6 +8.8%Operating income−35.3Net income−34.8Fiscal year 2019Revenue3.1 −32.8%Operating income−27.3Net income−26.6Fiscal year 2020Revenue2.2 −29.0%Operating income−21.5Net income−18.7Fiscal year 2021Revenue0.0 −100.0%Operating income−16.8Net income−16.8Fiscal year 2022Revenue1.5Operating income−11.5Net income−11.4EPS, diluted−1.32Fiscal year 2023Revenue0.4 −75.3%Operating income−17.7Net income−17.3EPS, diluted−1.98Fiscal year 2024Revenue0.1 −70.5%Operating income−15.1Net income−14.7EPS, diluted−19.25Fiscal year 2025Revenue0.1 +32.1%Operating income−12.6Net income−2.5EPS, diluted−1.70Fiscal year 2026Revenue0.1 −9.0%Operating income−11.5Net income−13.8EPS, diluted−5.35
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Revenue 4.2 4.6 3.1 2.2 0.0 1.5 0.4 0.1 0.1 0.1
Growth +8.8% −32.8% −29.0% −100.0% −75.3% −70.5% +32.1% −9.0%
Operating income −38.6 −35.3 −27.3 −21.5 −16.8 −11.5 −17.7 −15.1 −12.6 −11.5
Net income −38.4 −34.8 −26.6 −18.7 −16.8 −11.4 −17.3 −14.7 −2.5 −13.8
Growth
EPS, diluted n/a n/a n/a n/a n/a −1.32 −1.98 −19.25 −1.70 −5.35

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Operating marginNet margin
Fiscal year 2017Operating margin−911.9%Net margin−908.9%Free cash flow margin−722.0%Fiscal year 2018Operating margin−766.3%Net margin−756.1%Free cash flow margin−631.8%Fiscal year 2019Operating margin−882.4%Net margin−861.7%Free cash flow margin−661.7%Fiscal year 2020Operating margin−977.9%Net margin−852.0%Free cash flow margin−677.7%Fiscal year 2021Fiscal year 2022Operating margin−765.3%Net margin−763.2%Free cash flow margin−590.8%Fiscal year 2023Operating margin−4,792.2%Net margin−4,664.6%Free cash flow margin−3,460.5%Fiscal year 2024Operating margin−13,840.4%Net margin−13,459.6%Free cash flow margin−13,481.7%Fiscal year 2025Operating margin−8,761.1%Net margin−1,727.8%Free cash flow margin−6,579.2%Fiscal year 2026Operating margin−8,768.7%Net margin−10,567.2%Free cash flow margin−8,264.9%
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating margin −911.9% −766.3% −882.4% −977.9% n/a −765.3% −4,792.2% −13,840.4% −8,761.1% −8,768.7%
Net margin −908.9% −756.1% −861.7% −852.0% n/a −763.2% −4,664.6% −13,459.6% −1,727.8% −10,567.2%
Free cash flow margin −722.0% −631.8% −661.7% −677.7% n/a −590.8% −3,460.5% −13,481.7% −6,579.2% −8,264.9%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2017Operating cash flow−29.2Capital expenditure−1.4Free cash flow−30.5Fiscal year 2018Operating cash flow−28.9Capital expenditure−0.2Free cash flow−29.1Fiscal year 2019Operating cash flow−20.4Capital expenditure−0.1Free cash flow−20.5Fiscal year 2020Operating cash flow−14.9Capital expenditure0.0Free cash flow−14.9Buybacks0.0Fiscal year 2021Operating cash flow−13.3Capital expenditure−0.4Free cash flow−13.7Buybacks−0.0Fiscal year 2022Operating cash flow−8.5Capital expenditure−0.4Free cash flow−8.9Buybacks0.0Fiscal year 2023Operating cash flow−12.4Capital expenditure−0.4Free cash flow−12.8Fiscal year 2024Operating cash flow−14.7Capital expenditure−0.0Free cash flow−14.7Fiscal year 2025Operating cash flow−9.5Capital expenditure−0.0Free cash flow−9.5Fiscal year 2026Operating cash flow−10.8Capital expenditure0.0Free cash flow−10.8
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Operating cash flow −29.2 −28.9 −20.4 −14.9 −13.3 −8.5 −12.4 −14.7 −9.5 −10.8
Capital expenditure −1.4 −0.2 −0.1 0.0 −0.4 −0.4 −0.4 −0.0 −0.0 0.0
Free cash flow −30.5 −29.1 −20.5 −14.9 −13.7 −8.9 −12.8 −14.7 −9.5 −10.8
Growth
Buybacks n/a n/a n/a 0.0 −0.0 0.0 n/a n/a n/a n/a

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2017Cash62.8Shareholders’ equity62.4Fiscal year 2018Cash43.7Shareholders’ equity44.6Fiscal year 2019Cash36.5Shareholders’ equity36.3Fiscal year 2020Cash27.4Shareholders’ equity26.6Fiscal year 2021Cash37.4Shareholders’ equity39.2Fiscal year 2022Cash28.7Shareholders’ equity30.2Fiscal year 2023Cash15.3Shareholders’ equity15.3Fiscal year 2024Cash2.9Shareholders’ equity3.6Fiscal year 2025Cash11.3Shareholders’ equity10.5Fiscal year 2026Cash5.0Shareholders’ equity−1.1
FY2017FY2018FY2019FY2020FY2021FY2022FY2023FY2024FY2025FY2026
Cash 62.8 43.7 36.5 27.4 37.4 28.7 15.3 2.9 11.3 5.0
Shareholders’ equity 62.4 44.6 36.3 26.6 39.2 30.2 15.3 3.6 10.5 −1.1

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2026 · 10-K

Income statement

In millions of USD, except per-share figures; shares in millions. Fiscal years ending March, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2017 31 Mar 2017 FY2018 31 Mar 2018 FY2019 31 Mar 2019 FY2020 31 Mar 2020 FY2021 31 Mar 2021 FY2022 31 Mar 2022 FY2023 31 Mar 2023 FY2024† 31 Mar 2024 FY2025† 31 Mar 2025 FY2026† 31 Mar 2026
Revenue and profit
4.2 4.6 3.1 2.2 0.0 1.5 0.4 0.1 0.1 0.1
Growth +8.8% −32.8% −29.0% −100.0% −75.3% −70.5% +32.1% −9.0%
1.0 1.0 0.5 0.3 0.0 n/a n/a n/a 0.0 0.0
19.5 18.0 14.8 5.3 1.1 3.3 8.9 5.5 5.0 4.2
22.3 20.9 15.1 18.1 15.7 9.7 9.2 9.7 7.7 7.4
−38.6 −35.3 −27.3 −21.5 −16.8 −11.5 −17.7 −15.1 −12.6 −11.5
Growth
n/a n/a n/a n/a n/a n/a n/a n/a −2.5 −13.8
0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0 0.0
−38.4 −34.8 −26.6 −18.7 −16.8 −11.4 −17.3 −14.7 −2.5 −13.8
Growth
Per share
n/a n/a n/a n/a n/a −1.32 −1.98 −19.25 −1.70 −5.35
n/a n/a n/a n/a n/a −1.32 −1.98 −19.25 −1.70 −5.35
Growth
n/a n/a n/a n/a n/a 8.7 8.7 0.8 1.5 2.6
n/a n/a n/a n/a n/a 8.7 8.7 0.8 1.5 2.6
Growth +0.1% −91.3% +92.1% +76.8%

† The diluted share count jumps at 2024 and 2025 and 2026, so per-share figures either side of that column are not comparable. Usually a split, but the break lands on the restatement boundary rather than on the split date, because every column is that period’s latest filing.

Five years in brief

Worked out from the figures above, not from a press release
  • A net loss in 10 of 10 years on file.